Effect  ||| S:0 E:7 ||| NN
of  ||| S:7 E:10 ||| IN
weight  ||| S:10 E:17 ||| NN
reduction  ||| S:17 E:27 ||| NN
on  ||| S:27 E:30 ||| IN
leptin ||| S:30 E:36 ||| NN
,  ||| S:36 E:38 ||| ,
total  ||| S:38 E:44 ||| JJ
ghrelin  ||| S:44 E:52 ||| NN
and  ||| S:52 E:56 ||| CC
obestatin  ||| S:56 E:66 ||| JJ
concentrations  ||| S:66 E:81 ||| NNS
in  ||| S:81 E:84 ||| IN
prepubertal  ||| S:84 E:96 ||| JJ
children  ||| S:96 E:105 ||| NNS
The  ||| S:105 E:109 ||| DT
aim  ||| S:109 E:113 ||| NN
of  ||| S:113 E:116 ||| IN
the  ||| S:116 E:120 ||| DT
study  ||| S:120 E:126 ||| NN
was  ||| S:126 E:130 ||| VBD
to  ||| S:130 E:133 ||| TO
evaluate  ||| S:133 E:142 ||| VB
fasting  ||| S:142 E:150 ||| JJ
levels  ||| S:150 E:157 ||| NNS
of  ||| S:157 E:160 ||| IN
glucose ||| S:160 E:167 ||| NN
,  ||| S:167 E:169 ||| ,
insulin ||| S:169 E:176 ||| NN
,  ||| S:176 E:178 ||| ,
leptin ||| S:178 E:184 ||| NN
,  ||| S:184 E:186 ||| ,
total  ||| S:186 E:192 ||| JJ
ghrelin ||| S:192 E:199 ||| NN
,  ||| S:199 E:201 ||| ,
and  ||| S:201 E:205 ||| CC
obestatin  ||| S:205 E:215 ||| NN
in  ||| S:215 E:218 ||| IN
a  ||| S:218 E:220 ||| DT
group  ||| S:220 E:226 ||| NN
of  ||| S:226 E:229 ||| IN
prepubescent  ||| S:229 E:242 ||| JJ
obese  ||| S:242 E:248 ||| JJ
children  ||| S:248 E:257 ||| NNS
before  ||| S:257 E:264 ||| IN
and  ||| S:264 E:268 ||| CC
after  ||| S:268 E:274 ||| IN
weight  ||| S:274 E:281 ||| NN
loss ||| S:281 E:285 ||| NN
.  ||| S:285 E:287 ||| .
We  ||| S:287 E:290 ||| PRP
enrolled  ||| S:290 E:299 ||| VBD
64  ||| S:299 E:302 ||| CD
prepubescent  ||| S:302 E:315 ||| CD
obese  ||| S:315 E:321 ||| CD
children ||| S:321 E:329 ||| NNS
,  ||| S:329 E:331 ||| ,
but  ||| S:331 E:335 ||| CC
only  ||| S:335 E:340 ||| RB
35  ||| S:340 E:343 ||| CD
completed  ||| S:343 E:353 ||| VBD
the  ||| S:353 E:357 ||| DT
study  ||| S:357 E:363 ||| NN
( ||| S:363 E:364 ||| -LRB-
mean  ||| S:364 E:369 ||| JJ
age  ||| S:369 E:373 ||| NN
7.6  ||| S:373 E:377 ||| CD
+-  ||| S:377 E:380 ||| CD
0.9  ||| S:380 E:384 ||| CD
years ||| S:384 E:389 ||| NNS
,  ||| S:389 E:391 ||| ,
19  ||| S:391 E:394 ||| CD
females ||| S:394 E:401 ||| NNS
)  ||| S:401 E:403 ||| -RRB-
and  ||| S:403 E:407 ||| CC
20  ||| S:407 E:410 ||| CD
normal-weight  ||| S:410 E:424 ||| JJ
prepubescent  ||| S:424 E:437 ||| JJ
children  ||| S:437 E:446 ||| NNS
as  ||| S:446 E:449 ||| IN
controls ||| S:449 E:457 ||| NNS
.  ||| S:457 E:459 ||| .
Fasting  ||| S:459 E:467 ||| JJ
plasma  ||| S:467 E:474 ||| JJ
concentration  ||| S:474 E:488 ||| NN
of  ||| S:488 E:491 ||| IN
glucose ||| S:491 E:498 ||| NN
,  ||| S:498 E:500 ||| ,
insulin ||| S:500 E:507 ||| NN
,  ||| S:507 E:509 ||| ,
Homeostasis  ||| S:509 E:521 ||| NNP
Model  ||| S:521 E:527 ||| NNP
assessment  ||| S:527 E:538 ||| NN
for  ||| S:538 E:542 ||| IN
insulin  ||| S:542 E:550 ||| NN
resistance  ||| S:550 E:561 ||| NN
( ||| S:561 E:562 ||| -LRB-
HOMA-IR ||| S:562 E:569 ||| NNP
) ||| S:569 E:570 ||| -RRB-
,  ||| S:570 E:572 ||| ,
and  ||| S:572 E:576 ||| CC
leptin ||| S:576 E:582 ||| NN
,  ||| S:582 E:584 ||| ,
total  ||| S:584 E:590 ||| JJ
ghrelin ||| S:590 E:597 ||| NN
,  ||| S:597 E:599 ||| ,
and  ||| S:599 E:603 ||| CC
obestatin  ||| S:603 E:613 ||| JJ
levels  ||| S:613 E:620 ||| NNS
were  ||| S:620 E:625 ||| VBD
measured  ||| S:625 E:634 ||| VBN
at  ||| S:634 E:637 ||| IN
baseline  ||| S:637 E:646 ||| NN
and  ||| S:646 E:650 ||| CC
after  ||| S:650 E:656 ||| IN
a  ||| S:656 E:658 ||| DT
6-month  ||| S:658 E:666 ||| JJ
lifestyle  ||| S:666 E:676 ||| JJ
intervention  ||| S:676 E:689 ||| NN
( ||| S:689 E:690 ||| -LRB-
i.e.  ||| S:690 E:695 ||| FW
improved  ||| S:695 E:704 ||| JJ
nutrition  ||| S:704 E:714 ||| NN
and  ||| S:714 E:718 ||| CC
increased  ||| S:718 E:728 ||| VBD
physical  ||| S:728 E:737 ||| JJ
activity ||| S:737 E:745 ||| NN
) ||| S:745 E:746 ||| -RRB-
.  ||| S:746 E:748 ||| .
At  ||| S:748 E:751 ||| IN
baseline ||| S:751 E:759 ||| NN
,  ||| S:759 E:761 ||| ,
obese  ||| S:761 E:767 ||| JJ
children  ||| S:767 E:776 ||| NNS
showed  ||| S:776 E:783 ||| VBD
significantly  ||| S:783 E:797 ||| RB
( ||| S:797 E:798 ||| -LRB-
p  ||| S:798 E:800 ||| RB
less  ||| S:800 E:805 ||| JJR
than  ||| S:805 E:810 ||| IN
0.001 ||| S:810 E:815 ||| CD
)  ||| S:815 E:817 ||| -RRB-
higher  ||| S:817 E:824 ||| JJR
leptin  ||| S:824 E:831 ||| NNS
and  ||| S:831 E:835 ||| CC
obestatin  ||| S:835 E:845 ||| JJ
levels ||| S:845 E:851 ||| NNS
,  ||| S:851 E:853 ||| ,
and  ||| S:853 E:857 ||| CC
lower  ||| S:857 E:863 ||| JJR
total  ||| S:863 E:869 ||| JJ
ghrelin  ||| S:869 E:877 ||| JJ
concentrations  ||| S:877 E:892 ||| NNS
than  ||| S:892 E:897 ||| IN
control  ||| S:897 E:905 ||| NN
subjects ||| S:905 E:913 ||| NNS
.  ||| S:913 E:915 ||| .
Weight  ||| S:915 E:922 ||| NN
loss  ||| S:922 E:927 ||| NN
significantly  ||| S:927 E:941 ||| RB
( ||| S:941 E:942 ||| -LRB-
p  ||| S:942 E:944 ||| RB
less  ||| S:944 E:949 ||| JJR
than  ||| S:949 E:954 ||| IN
0.001 ||| S:954 E:959 ||| CD
)  ||| S:959 E:961 ||| -RRB-
diminished  ||| S:961 E:972 ||| VBN
plasma  ||| S:972 E:979 ||| JJ
leptin  ||| S:979 E:986 ||| NN
and  ||| S:986 E:990 ||| CC
insulin  ||| S:990 E:998 ||| NN
levels  ||| S:998 E:1005 ||| NNS
and  ||| S:1005 E:1009 ||| CC
increased  ||| S:1009 E:1019 ||| JJ
ghrelin  ||| S:1019 E:1027 ||| NN
and  ||| S:1027 E:1031 ||| CC
obestatin  ||| S:1031 E:1041 ||| JJ
concentrations ||| S:1041 E:1055 ||| NNS
.  ||| S:1055 E:1057 ||| .
Weight  ||| S:1057 E:1064 ||| NN
loss  ||| S:1064 E:1069 ||| NN
in  ||| S:1069 E:1072 ||| IN
prepubescent  ||| S:1072 E:1085 ||| JJ
children  ||| S:1085 E:1094 ||| NNS
is  ||| S:1094 E:1097 ||| VBZ
associated  ||| S:1097 E:1108 ||| VBN
with  ||| S:1108 E:1113 ||| IN
a  ||| S:1113 E:1115 ||| DT
significant  ||| S:1115 E:1127 ||| JJ
change  ||| S:1127 E:1134 ||| NN
in  ||| S:1134 E:1137 ||| IN
leptin ||| S:1137 E:1143 ||| NN
,  ||| S:1143 E:1145 ||| ,
ghrelin  ||| S:1145 E:1153 ||| NN
and  ||| S:1153 E:1157 ||| CC
obestatin  ||| S:1157 E:1167 ||| JJ
concentrations ||| S:1167 E:1181 ||| NNS
.  ||| S:1181 E:1183 ||| .
These  ||| S:1183 E:1189 ||| DT
results  ||| S:1189 E:1197 ||| NNS
confirm  ||| S:1197 E:1205 ||| VBP
the  ||| S:1205 E:1209 ||| DT
hypothesis  ||| S:1209 E:1220 ||| NN
that  ||| S:1220 E:1225 ||| IN
levels  ||| S:1225 E:1232 ||| NNS
of  ||| S:1232 E:1235 ||| IN
these  ||| S:1235 E:1241 ||| DT
hormones  ||| S:1241 E:1250 ||| NNS
are  ||| S:1250 E:1254 ||| VBP
closely  ||| S:1254 E:1262 ||| RB
associated  ||| S:1262 E:1273 ||| VBN
with  ||| S:1273 E:1278 ||| IN
obesity  ||| S:1278 E:1286 ||| NN
in  ||| S:1286 E:1289 ||| IN
childhood  ||| S:1289 E:1299 ||| NN
and  ||| S:1299 E:1303 ||| CC
might  ||| S:1303 E:1309 ||| MD
take  ||| S:1309 E:1314 ||| VB
part ||| S:1314 E:1318 ||| NN
,  ||| S:1318 E:1320 ||| ,
as  ||| S:1320 E:1323 ||| IN
consequence  ||| S:1323 E:1335 ||| NN
but  ||| S:1335 E:1339 ||| CC
not  ||| S:1339 E:1343 ||| RB
as  ||| S:1343 E:1346 ||| IN
a  ||| S:1346 E:1348 ||| DT
cause ||| S:1348 E:1353 ||| NN
,  ||| S:1353 E:1355 ||| ,
in  ||| S:1355 E:1358 ||| IN
glucose ||| S:1358 E:1365 ||| NN
,  ||| S:1365 E:1367 ||| ,
fat ||| S:1367 E:1370 ||| JJ
,  ||| S:1370 E:1372 ||| ,
and  ||| S:1372 E:1376 ||| CC
energy  ||| S:1376 E:1383 ||| NN
metabolism ||| S:1383 E:1393 ||| NN
.  ||| S:1393 E:1395 ||| .
